PAVmed Analyst Ratings
PAVmed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/20/2023 | 226.87% | Cantor Fitzgerald | $4 → $1.5 | Downgrades | Overweight → Neutral |
| 01/18/2023 | 226.87% | Lake Street | $5 → $1.5 | Maintains | Buy |
| 08/17/2022 | 989.56% | Lake Street | $7 → $5 | Maintains | Buy |
| 03/30/2021 | 1643.3% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 11/05/2020 | 989.56% | Ascendiant Capital | → $5 | Initiates Coverage On | → Buy |
| 10/13/2020 | 989.56% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 06/28/2018 | 989.56% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 01/20/2023 | 226.87% | 康托·菲茨杰拉德 | $4→$1.5 | 评级下调 | 超重→中性 |
| 01/18/2023 | 226.87% | 莱克街 | $5→$1.5 | 维护 | 买 |
| 2022/08/17 | 989.56% | 莱克街 | $7→$5 | 维护 | 买 |
| 03/30/2021 | 1643.3% | 康托·菲茨杰拉德 | →$8 | 开始承保 | →超重 |
| 11/05/2020 | 989.56% | 《上升之都》 | →$5 | 开始承保 | →购买 |
| 10/13/2020 | 989.56% | 莱克街 | →$5 | 开始承保 | →购买 |
| 2018/06/28 | 989.56% | Maxim集团 | →$5 | 开始承保 | →购买 |
What is the target price for PAVmed (PAVM)?
PAVmed(PAVM)的目标价是多少？
The latest price target for PAVmed (NASDAQ: PAVM) was reported by Cantor Fitzgerald on January 20, 2023. The analyst firm set a price target for $1.50 expecting PAVM to rise to within 12 months (a possible 226.87% upside). 3 analyst firms have reported ratings in the last year.
康托·菲茨杰拉德于2023年1月20日报道了PAVmed(纳斯达克代码：PAVM)的最新目标价。这家分析公司将目标价定为1.5美元，预计pvm将在12个月内升至(可能上涨226.87%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for PAVmed (PAVM)?
PAVmed(PAVM)的最新分析师评级是多少？
The latest analyst rating for PAVmed (NASDAQ: PAVM) was provided by Cantor Fitzgerald, and PAVmed downgraded their neutral rating.
纳斯达克(Sequoia Capital：PAVM)的最新分析师评级由康托·菲茨杰拉德提供，PAVmed下调了其中性评级。
When is the next analyst rating going to be posted or updated for PAVmed (PAVM)?
PAVmed(PAVM)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PAVmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PAVmed was filed on January 20, 2023 so you should expect the next rating to be made available sometime around January 20, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与PAVmed的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。PAVmed的上一次评级是在2023年1月20日提交的，所以你应该预计下一次评级将在2024年1月20日左右的某个时候公布。
Is the Analyst Rating PAVmed (PAVM) correct?
分析师评级PAVmed(PAVM)正确吗？
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a downgraded with a price target of $4.00 to $1.50. The current price PAVmed (PAVM) is trading at is $0.46, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的PAVmed(PAVM)评级被下调，目标价为4.00美元至1.50美元。目前PAVmed(PAVM)的交易价格为0.46美元，超出了分析师的预测区间。